Loading...
Market
Group with highest satisfaction with Medicare's $2,000 drug cost cap by end of 2025?
2
Resolution / Starting Odds
Low-income beneficiaries • 25%
Middle-income beneficiaries • 25%
High-income beneficiaries • 25%
Pharmaceutical companies • 25%
Surveys or reports from healthcare organizations or research institutions
Story
Medicare Implements $2,000 Annual Cap on Prescription Drug Costs Under Inflation Reduction Act
Dec 31, 2024, 09:50 PM
Starting January 1, Medicare will implement a new annual cap on out-of-pocket prescription drug costs at $2,000 for beneficiaries, a move anticipated to save millions of Americans money on their medications. This cap, part of the Inflation Reduction Act, will apply to drugs purchased at pharmacies or through mail order, offering significant relief to those who require multiple medications. The provision aims to limit the financial burden on Medicare enrollees, who previously faced no limit on out-of-pocket costs for medications covered by their Part D drug plans.
View original story
Similar markets
More than 90% • 25%
Less than 50% • 25%
50% to 70% • 25%
70% to 90% • 25%
50% to 70% • 25%
More than 90% • 25%
Less than 50% • 25%
71% to 90% • 25%
Texas • 25%
New York • 25%
California • 25%
Florida • 25%
Less than 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
More than 30% • 25%
$5 billion to $10 billion • 25%
Less than $5 billion • 25%
$10 billion to $15 billion • 25%
More than $15 billion • 25%
Yes • 50%
No • 50%
More than $2,000 • 25%
Less than $500 • 25%
$500 to $1,000 • 25%
$1,000 to $2,000 • 25%
$10 billion to $15 billion • 25%
More than $15 billion • 25%
Less than $5 billion • 25%
$5 billion to $10 billion • 25%
Yes • 50%
No • 50%
Insulin • 25%
Cardiovascular drugs • 25%
Cancer drugs • 25%
Other • 25%
Chronic condition medications • 25%
Other • 25%
Diabetes medications • 25%
Cancer treatments • 25%